We report two anesthetic cases of pulmonary hypertension who were treated with prostaglandin E
1 (PGE
1), dobutamine (DOB), or tolazoline, conversely worsening the pulmonary hypertension.
Case 1 was a 45-year-old female with chronic pulmonary thromboembolism. At the beginning of a total hysterectomy, her mean pulmonary arterial pressure (PAP) was 40mmHg, although cardiac output (CO) was 3.9l/min, and her systemic arterial blood pressure (AOP) was 85mmHg. PGE
1 (0.02μg/kg/min) was administered to treat the pulmonary hypertension. CO increased to 5.3l/min, corresponding with an increase in PAP to 60mmHg, whereas AOP decreased to 50mmHg. These hemodynamic changes were normalized by replacing PGE
1 with nitroglycerin (TNG) (0.5μg/kg/min).
Case 2 was a 28-year-old male with primary pulmonary hypertension. During surgery for subdural hematoma, his PAP and AOP were 60mmHg and 85mmHg, respectively. Administration of DOB (5μg/kg/min) caused an increase in CO to 12l/min as well as associated elevation of PAP (75mmHg). Additional administration of tolazoline (5μg/kg/min) resulted in further elevation of PAP, thus exceeding AOP. These hemodynamics normalized following the discontinuation of the drugs.
It is suggested that PGE
1, DOB or tolazoline exerted a greater effect on increasing CO than on reducing pulmonary vascular resistance in these two cases. The excessive increase in CO overloaded the right ventricle and lead to an elevation in PAP. Careful selection of cardiotonic drugs is needed in the treatment of pulmonary hypertension.
View full abstract